{"title":"梯瓦英国有限公司诉吉利德科学公司","authors":"","doi":"10.1093/rpc/rcz009","DOIUrl":null,"url":null,"abstract":"\n Supplementary protection certificates – Anti-retroviral medication – Validity – Combination of active ingredients – Construction of art.3(a) of the SPC Regulation – Whether product “protected by the basic patent in force” – Whether extent of protection the relevant test – Issue referred to Court of Justice – Interpretation and application of judgment of Court of Justice","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Teva UK Ltd v Gilead Sciences Inc\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcz009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Supplementary protection certificates – Anti-retroviral medication – Validity – Combination of active ingredients – Construction of art.3(a) of the SPC Regulation – Whether product “protected by the basic patent in force” – Whether extent of protection the relevant test – Issue referred to Court of Justice – Interpretation and application of judgment of Court of Justice\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcz009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcz009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Supplementary protection certificates – Anti-retroviral medication – Validity – Combination of active ingredients – Construction of art.3(a) of the SPC Regulation – Whether product “protected by the basic patent in force” – Whether extent of protection the relevant test – Issue referred to Court of Justice – Interpretation and application of judgment of Court of Justice
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
